• Explore /
  • Poster
  • / A phase 1/2 dose escalation and expansion study of sonodynamic therapy with SONALA-001 in combination with Exablate 4000 Type 2.0 MR-guided focused ultrasound in patients with progressive or recurrent glioblastoma (rGBM).

A phase 1/2 dose escalation and expansion study of sonodynamic therapy with SONALA-001 in combination with Exablate 4000 Type 2.0 MR-guided focused ultrasound in patients with progressive or recurrent glioblastoma (rGBM).

Abstract Poster

Authors

null

Dimitris Placantonakis

NYU Medical Center-Perlmutter Cancer Center, New York, NY

Dimitris Placantonakis , Matthew Grabowski , Terry C. Burns , Nicholas A. Butowski , Peter Fenn , Ryan Clanton , Lenora Henry , Wyatt Potter , Corina Andresen , Stuart Marcus , Ely Benaim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

NCT05370508

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS2101)

DOI

10.1200/JCO.2024.42.16_suppl.TPS2101

Abstract #

TPS2101

Poster Bd #

394a

Abstract Disclosures

Similar Posters

First Author: Patrick Y. Wen

First Author: Patrick Y. Wen

First Author: Krish Patel

First Author: Jonathan Coleman